Liquidia Corp (LQDA) Historical Volatility

Tracking LQDA historical volatility helps you see how much Liquidia Corp's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, Liquidia Corp's HV tells you what really happened. Use our scanner to monitor LQDA 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.

Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The LQDA 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing Liquidia Corp's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts Liquidia Corp's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where LQDA HV is running hot, cold, or in line. Make the LQDA 30 day historical volatility — and every other window — work for your edge instead of against it.